DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Bardia A, Mayer IA, Vahdat LT. et al.
Sacituzumab Govitecan-hiziy in Refractory Metastatic Triple-Negative Breast Cancer.
N Engl J Med 2019;
380: 741-751
We do not assume any responsibility for the contents of the web pages of other providers.